Bo Kruse Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

Bo Kruse is EVP, CFO, SECRY & TREAS. of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 210,877 shares of YMAB, which is worth approximately $2.92 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 31,371 shares (Common Stock) at a price of $12.07 per share, resulting in proceeds of $378,647. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K

0% 3M change

9.39% 12M change

Total Value Held $2.92 Million

Bo Kruse Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	SELL Open market or private sale	$378,647 $12.07 p/Share	31,371 Reduced 12.95%	210,877 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	$62,742 $2.0 p/Share	31,371 Added 11.47%	242,248 Common Stock
May 30 2024	SELL Open market or private sale	$344,406 $12.03 p/Share	28,629 Reduced 11.95%	210,877 Common Stock
May 30 2024	BUY Exercise of conversion of derivative security	$57,258 $2.0 p/Share	28,629 Added 10.68%	239,506 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	18,100 Added 7.9%	210,877 Common Stock
Jan 17 2023	BUY Grant, award, or other acquisition	-	11,700 Added 5.72%	192,777 Common Stock
Feb 22 2022	SELL Open market or private sale	$31,400 $7.85 p/Share	4,000 Reduced 2.16%	181,077 Common Stock
Feb 04 2022	SELL Open market or private sale	$31,880 $7.97 p/Share	4,000 Reduced 2.12%	185,077 Common Stock
Jan 24 2022	SELL Open market or private sale	$39,360 $9.84 p/Share	4,000 Reduced 2.07%	189,077 Common Stock
Jan 04 2022	SELL Open market or private sale	$68,480 $17.12 p/Share	4,000 Reduced 2.03%	193,077 Common Stock
Dec 22 2021	SELL Open market or private sale	$65,440 $16.36 p/Share	4,000 Reduced 1.99%	197,077 Common Stock
Dec 06 2021	SELL Open market or private sale	$65,400 $16.35 p/Share	4,000 Reduced 1.95%	201,077 Common Stock
Nov 22 2021	SELL Open market or private sale	$72,360 $18.09 p/Share	4,000 Reduced 1.91%	205,077 Common Stock
Nov 04 2021	SELL Open market or private sale	$110,160 $27.54 p/Share	4,000 Reduced 1.88%	209,077 Common Stock
Oct 22 2021	SELL Open market or private sale	$103,760 $25.94 p/Share	4,000 Reduced 1.84%	213,077 Common Stock
Oct 04 2021	SELL Open market or private sale	$115,120 $28.78 p/Share	4,000 Reduced 1.81%	217,077 Common Stock
Sep 22 2021	SELL Open market or private sale	$123,280 $30.82 p/Share	4,000 Reduced 1.78%	221,077 Common Stock
Sep 07 2021	SELL Open market or private sale	$128,120 $32.03 p/Share	4,000 Reduced 1.75%	225,077 Common Stock
Aug 23 2021	SELL Open market or private sale	$114,400 $28.6 p/Share	4,000 Reduced 1.72%	229,077 Common Stock
Aug 04 2021	SELL Open market or private sale	$134,880 $33.72 p/Share	4,000 Reduced 1.69%	233,077 Common Stock
Jul 22 2021	SELL Open market or private sale	$138,000 $34.5 p/Share	4,000 Reduced 1.66%	237,077 Common Stock
Jul 06 2021	SELL Open market or private sale	$136,600 $34.15 p/Share	4,000 Reduced 1.63%	241,077 Common Stock
Jun 22 2021	SELL Open market or private sale	$144,680 $36.17 p/Share	4,000 Reduced 1.61%	245,077 Common Stock
Jun 04 2021	SELL Open market or private sale	$133,920 $33.48 p/Share	4,000 Reduced 1.58%	249,077 Common Stock
May 24 2021	SELL Open market or private sale	$142,440 $35.61 p/Share	4,000 Reduced 1.56%	253,077 Common Stock

Bo Kruse

EVP, CFO, SECRY & TREAS.

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Value

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB

Account